Independent Medical Education Grants
Due to the recent news that Oncopeptides has voluntarily withdrawn PEPAXTO® in the U.S. and will close the U.S. commercial business unit, we will not consider any grants for 2022, unfortunately. We sincerely thank you for your support and interest in Oncopeptides and the treatment of patients with relapsed or refractory multiple myeloma.
Oncopeptides offers support to meritorious grant proposals from accredited providers towards Continuing Medical Education (CME) of all Health Care Professionals (HCPs) in USA. Currently, we are accepting grants for education activities in the unmet need of Relapsed and Refractory Multiple Myeloma (RRMM). We request providers to submit their grant proposals through our online grant application and allow at least 8 weeks from the date of submission for our response.